Mean frequencies of unique core region nucleotide sequences for each patient subpopulation
. | Mean complexity . | . | . | ||
|---|---|---|---|---|---|
| Time point . | Progressors (n = 10) . | Nonprogressors (n = 10) . | Difference: progressor-nonprogressor* . | ||
| Coinfected (n = 16) | |||||
| Early | 0.56 (SE, 0.11) | 0.72 (SE, 0.06) | - 0.16 | ||
| Late | 0.61 (SE, 0.10) | 0.73 (SE, 0.07) | - 0.12 | ||
| Monoinfected (n = 4) | |||||
| Early | 0.47 (SE, 0.20) | 0.92 (SE, 0.08) | - 0.45 | ||
| Late | 0.89 (SE, 0.11) | 0.83 (SE, 0.08) | 0.06 | ||
| Total | |||||
| Early | 0.54 (SE, 0.09) | 0.76 (SE, 0.05) | - 0.22 | ||
| Late | 0.67 (SE, 0.09) | 0.75 (SE, 0.06) | - 0.08 | ||
| Late-Early | 0.13 (SE, 0.13) | - 0.01 (SE, 0.06) | 0.14 | ||
. | Mean complexity . | . | . | ||
|---|---|---|---|---|---|
| Time point . | Progressors (n = 10) . | Nonprogressors (n = 10) . | Difference: progressor-nonprogressor* . | ||
| Coinfected (n = 16) | |||||
| Early | 0.56 (SE, 0.11) | 0.72 (SE, 0.06) | - 0.16 | ||
| Late | 0.61 (SE, 0.10) | 0.73 (SE, 0.07) | - 0.12 | ||
| Monoinfected (n = 4) | |||||
| Early | 0.47 (SE, 0.20) | 0.92 (SE, 0.08) | - 0.45 | ||
| Late | 0.89 (SE, 0.11) | 0.83 (SE, 0.08) | 0.06 | ||
| Total | |||||
| Early | 0.54 (SE, 0.09) | 0.76 (SE, 0.05) | - 0.22 | ||
| Late | 0.67 (SE, 0.09) | 0.75 (SE, 0.06) | - 0.08 | ||
| Late-Early | 0.13 (SE, 0.13) | - 0.01 (SE, 0.06) | 0.14 | ||
Frequencies were determined by the proportion of unique nucleotide sequences to the number of clones assessed for each patient at early and late time points within the core-coding region.
P = NS for all comparisons.